Four strategies for very early rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I (hs-cTnI) have been identified. It remains unclear which strategy is most attractive for clinical application.
A bout 10% of all emergency department (ED) consultations are caused by patients with symptoms suggestive of acute myocardial infarction (AMI). 1 Rapid identification of AMI as a life-threatening disorder is important for the early initiation of appropriate, evidencebased therapy to safely rule out or rule in AMI. ECG and cardiac troponin (cTn) form the diagnostic cornerstones and complement clinical assessment. 2, 3 The introduction of sensitive and high-sensitivity cardiac troponin (hs-cTn) assays enabled reliable measurement of cTn concentrations in the normal range, 4 and improved diagnostic accuracy for AMI at presentation. 5, 6 Studies in healthy individuals have revealed substantial analytic differences among sensitive and hs-cTn assays and documented that, among the clinically available cTn assays, only the hs-cTnI (ARCHITECT STAT) assay consistently meets the criteria for high-sensitivity: detectable cTn blood concentrations in >50% of healthy individuals. [7] [8] [9] [10] Four different diagnostic strategies applying this hs-cTnI assay have been developed recently that allow the very early triage toward rule-out of AMI either with a single measurement at ED presentation or 2 measurements within the first hour. 2, [11] [12] [13] [14] One strategy also provides guidance for rule-in. These pilot studies showed high sensitivity and negative predictive value (NPV) to rule out AMI, but also remarkable differences in effectiveness as quantified by the percentage of patients eligible for rule-out by the 4 hs-cTnI-based strategies. [11] [12] [13] Unfortunately, methodological differences between these studies including patient characteristics and adjudication details (eg, number of patients with serial hs-cTn measurements available for the adjudication of the final diagnosis) limit the comparison of the different strategies among each other. Accordingly, the critical question, which strategy should be favored for clinical implementation in routine care, remained unanswered. [11] [12] [13] To address this major gap in knowledge, we aimed to directly compare all 4 very early rule-out strategies in a large multicenter study.
METHODS Study Design and Population
The APACE study (Advantageous Predictors of Acute Coronary Syndrome Evaluation) is an ongoing prospective international multicenter study with 12 centers in 5 European countries designed and coordinated by the University Hospital Basel, Switzerland (ClinicalTrials.gov, number NCT00470587). 5, 11, 13, [15] [16] [17] [18] [19] [20] The APACE study aims to advance the early diagnosis of AMI.
Patients presenting to the ED with symptoms suggestive of AMI (such as acute chest discomfort and angina pectoris) with an onset or peak within the past 12 hours and an age >18 were recruited. Patients with terminal kidney failure requiring dialysis were excluded. The study was conducted according to the principles of the Declaration of Helsinki and approved by the local ethics committees. Written informed consent was obtained from all patients.
For this analysis, patients with ST-segment-elevation myocardial infarction, patients with an unknown diagnosis after adjudication and at least 1 elevated hs-cTnT level possibly indicating AMI, and patients with missing blood samples or hs-cTnI measurements at 1 hour, as well, were excluded. The most common reasons for missing samples after 1 hour were early transfer to the catheter laboratory or coronary care unit and diagnostic procedures around the 1-hour window that precluded blood draw at 1 hour.
The authors designed the study, gathered, and analyzed the data according to the STARD (Standards for Reporting of Diagnostic Accuracy) guidelines for studies of diagnostic accuracy (online-only Data Supplement Table I ), vouched for the data and analysis, wrote the article, and decided to publish.
Routine Clinical Assessment
Patients underwent clinical assessment that included medical history, physical examination, standard blood test including serial measurements of local (hs)-cTn, 12-lead ECG, chest radiography, continuous ECG rhythm monitoring, and pulse oximetry. Management of patients was left to the discretion of the attending physician.
Clinical Perspective
What Is New?
• This is the first study directly comparing 4 recently developed very early rule-out strategies for acute myocardial infarction to help for clinicians in the selection of the most attractive strategy for routine clinical care.
• Overall, all 4 rule-out strategies balanced effectiveness and safety equally well.
• The single cutoff strategy was found to have significantly lower sensitivity than the other strategies in patients presenting early after chest pain onset.
• ECG findings provide little incremental value regarding sensitivity and negative predictive value on top of the respective high-sensitivity cardiac troponin I-based strategies.
What Are the Clinical Implications?
• Overall, all 4 strategies seemed to balance safety and effectiveness equally well and seemed to be valid options for routine clinical care.
• The single cutoff strategy should not be used in patients presenting early after chest pain onset.
• The single cutoff strategy, the 1-hour algorithm and the 0/1-hour algorithm allow the triage toward ruleout of acute myocardial infarction in more than half of consecutive patients presenting with suspected acute myocardial infarction to the emergency department.
Adjudicated Final Diagnosis
Adjudication of the final diagnosis was performed by 2 independent cardiologists at the core laboratory (University Hospital Basel) applying the universal definition of AMI by using 2 sets of data: first, all available medical records obtained during clinical care including history, physical examination, results of laboratory testing including serial clinical (hs)-cTn levels, radiological testing, ECG, echocardiography, cardiac exercise test, lesion severity, and morphology in coronary angiography, pertaining to the patient from the time of ED presentation to 90-day follow-up; second, study-specific assessments including detailed chest pain characteristics using 34 predefined criteria, serial hs-cTnT blood concentrations obtained from study samples, and clinical follow-up by telephone and mail. In situations of disagreement about the diagnosis, cases were reviewed and adjudicated in conjunction with a third cardiologist. AMI was defined and (hs-)cTn was interpreted as recommended in the current guidelines. 3, [21] [22] [23] [24] In brief, myocardial infarction was diagnosed when there was evidence of myocardial necrosis in association with a clinical setting consistent with myocardial ischemia. Myocardial necrosis was diagnosed by at least 1 cTn value above the 99th percentile together with a significant rising or falling. The criteria used to define a rise or fall in conventional cTn and hs-cTnT are described in detail in the Methods in the online-only Data Supplement. All other patients were classified in the categories of unstable angina, noncardiac chest pain, cardiac but noncoronary disease (eg, tachyarrhythmias, perimyocarditis), and symptoms of unknown origin with normal levels of hs-cTnT.
Investigational hs-cTnI Measurements
Blood samples for determination of hs-cTnI (ARCHITECT STAT high-sensitivity troponin I, Abbott Laboratories) were collected in serum tubes at presentation to the ED and after 1 hour. After centrifugation (30 minutes, 3000 relative centrifugal force, 4°C), samples were frozen at -80°C until assayed in a blinded fashion in a dedicated core laboratory. According to the manufacturer, the hs-cTnI assay has a 99th percentile concentration of 26.2 ng/L with a corresponding coefficient of variation of <5% and a limit of detection (LOD) of 1.9 ng/L. [7] [8] [9] Estimated glomerular filtration rate was calculated using the abbreviated Modification of Diet in Renal Disease formula. 25 
Follow-Up and Clinical End Points
Patients were contacted 3, 12, and 24 months after discharge by telephone calls or in written form. Information regarding death during follow-up was furthermore obtained from the patient's hospital notes, the family physician's records, and the national registry on mortality. The primary prognostic end point was 2-year all-cause mortality.
Hs-cTnI-Based Very Early Rule-Out Strategies
The 4 rule-out strategies are shown in online-only Data Supplement Figure I . The first strategy is the LOD approach using very low hs-cTnI blood concentrations below the LOD of this assay (<2 ng/L) to rule out AMI. 13 The second strategy is the single cutoff approach 12 using hs-cTnI concentrations at presentation of <5 ng/L to rule out AMI. 12 The third strategy is the hs-cTnI 1-hour algorithm, in which hs-cTnI concentrations of <5 ng/L at presentation and an absolute change of <2 ng/L within the first hour allow rule-out of AMI. 2, 11 The fourth strategy is the 0/1-hour algorithm, recommended in the 2015 Guidelines of the European Society of Cardiology, 2, 11 which is a combination of the LOD approach and the hs-cTnI 1-hour algorithm. 2, 11 Secondary analysis included a direct comparison of the 4 strategies with the 0/3-hour algorithm in the subgroup of patients that also had a 3-hour sample available.
Statistical Analysis
Continuous variables are described as median with interquartile range and categorical variables by numbers and percentages. Differences in baseline characteristics between patients with and without AMI were assessed using the Mann-Whitney U test for continuous variables and the Pearson χ 2 test for categorical variables.
Sensitivity and NPV were used to quantify the safety of the rule-out strategies. The percentage of patients eligible for ruleout of AMI was used to quantify effectiveness. The effectiveness does not determine how many patients are correctly ruled out, it only shows the number of patients triaged toward ruleout when presenting to the ED with chest pain irrespective of whether they have the final diagnosis of AMI or not.
To further examine the relationship between safety and effectiveness when applying a single cutoff level approach, sensitivity, NPV, and the percentage of patients eligible for rule-out were plotted together for each individual blood concentration of hs-cTnI at presentation. In addition, figures were constructed to further highlight the relationship between resulting effectiveness and sensitivity/NPV of each strategy. Given previous evidence suggesting suboptimal performance of some of these very early algorithms in patients presenting to the ED very soon (≤2 hours) after chest pain onset, subgroup analyses in this vulnerable group of patients were predefined. Further subgroup analyses were performed for patients presenting within 2 to 4 hours from chest pain onset, as well as according to sex, age, presence or absence of coronary artery disease, and estimated glomerular filtration rate. For calculation of differences between the resulting sensitivities in subgroups, we constructed 2×2 tables containing only truepositive and false-negative patients and calculated the sensitivities for each group (eg, sensitivity for patients with chest pain onset ≤2 hours versus sensitivity for patients with chest pain onset >2 hours). Differences between resulting sensitivities were assessed using the Pearson χ 2 test. Two-year survival according to the rule-out classification of each strategy was plotted in Kaplan-Meier curves and differences between the LOD approach and each of the other strategies were calculated using the log-rank test. The composite of major adverse cardiac events (MACE) within 30-day follow-up including all-cause mortality, AMI, cardiogenic shock, ventricular tachyarrhythmias, or higher-degree atrioventricular block was used as a secondary prognostic end point. All hypothesis testing was 2-tailed and P values of <0.05 were considered statistically significant. Statistical analyses were performed using SPSS for Windows 23.0 (SPSS Inc) and MedCalc 9.6.4.0 (MedCalc Software).
RESULTS

Characteristics of Patients
From April 2006 to August 2015, a total of 2828 patients eligible for this analysis were enrolled (online-only Data Supplement Figure II) . Baseline characteristics are shown in Table 1 . Patients with AMI were significantly older, had more risk factors, and more often had previously known coronary artery disease or peripheral artery disease in comparison with patients with other final diagnoses (all P<0.001).
Adjudicated Final Diagnosis
The adjudicated final diagnosis was AMI in 451 patients (16%); unstable angina in 272 (10%); cardiac symptoms of origin other than coronary artery disease, such as tachyarrhythmia, Tako-Tsubo cardiomyopathy, heart failure, or myocarditis in 427 (15%); A, Direct comparison of the performances of the 4 very early rule-out strategies. B, Relationship between effectiveness and sensitivity of the 4 very early rule-out strategies. C, Relationship between effectiveness and negative predictive value of the 4 very early rule-out strategies. *Chest pain onset >3 hours. AMI indicates acute myocardial infarction; CI, confidence interval; hs-cTnI, high-sensitivity cardiac troponin I; NPV, negative predictive value; NSTEMI, non-ST-segment-elevation myocardial infarction; and Sens., sensitivity.
noncardiac symptoms in 1565 (55%); and unknown in 113 patients (4%).
Performance of the Very Early Rule-Out Strategies
Performance characteristics of all 4 rule-out strategies are shown in Figure 1A through 1C. The LOD approach ruled out 453 patients (16%) with a sensitivity of 100% (95% confidence interval [CI], 99.2%-100%) and a NPV of 100% (95% CI, 99.2%-100%). No patient (0%) with AMI was incorrectly ruled out. The single cutoff approach classified 1516 patients (54%) as rule-out, which resulted in a sensitivity of 97.1% (95% CI, 95.1%-98.3%) and a NPV of 99.1% (95% CI, 98.5%-99.5%). Thirteen patients (0.9%) had AMI and were incorrectly ruled out. The hs-cTnI 1-hour algorithm classified 1459 patients (52%) as ruled out with a sensitivity of 98.4% (95% CI, 96.8%-99.2%) and a NPV of 99.5% (95% CI, 99%-99.8%). Seven patients (0.5%) had AMI and were incorrectly ruled out. Finally, the hs-cTnI 0/1-hour algorithm ruled out 1463 patients (52%) with a sensitivity of 98.4 (95% CI, 96.8%-99.2%) and a NPV of 99.5% (95% CI, 99%-99.8%). Seven patients (0.5%) had AMI and were incorrectly ruled out.
Detailed information on incorrectly ruled out patients with a final diagnosis of AMI is given in Table 2 . Additional information on patients excluded from the main analyses and the respective specificities and positive predictive values of the hs-cTnI-based rule-out strategies is reported in the online-only Data Supplement.
Reciprocal Relationship Between Safety and Effectiveness for Various Very Low Concentrations of hs-cTnI
Various low concentrations of hs-cTnI from ≤1 ng/L to <10 ng/L at presentation were tested as thresholds and sensitivity and NPV were calculated (Figure 2) . 
Subgroup Analyses
A total of 744 patients (26%) presented within 2 hours from chest pain onset. In these patients, the LOD approach classified 148 patients (20%) as rule-out with a sensitivity of 100% (95% CI, 96.9%-100%) and a NPV 100% (95% CI, 97.5%-100%). Using the single cutoff approach, 453 patients (61%) were ruled out, which resulted in a sensitivity of 94.2% (95% CI, 88.4%-97.1%) and NPV 98.5% (95% CI, 96.8%-99.2%). The hs-cTnI 1-hour algorithm and the hs-cTnI 0/1-hour algorithm ruled out 422 patients (57%) with a resulting sensitivity of 98.3% (95% CI, 94.1%-99.5%) and a NPV of 99.5% (95% CI, 98.3%-99.9%; Figure 3 , online-only Data Supplement Figure III and online-only Data Supplement Figure IV) . A total of 593 of 2828 patients (21%) presented within 2 to 4 hours after chest pain onset. Among these patients, the LOD strategy ruled out 92 of 593 patients (15.5%) with a sensitivity of 100% (95% CI, 95.8%-100%) and a NPV of 100% (95% CI, 96.1%-100%), the single cutoff strategy ruled out 316 of 593 patients (53.3%) with a sensitivity of 97.7% (95% CI, 91.8%-99.7%) and a NPV of 99.4% (95% CI, 97.7%-99.9%), the 1-hour algorithm ruled out 309of 593 patients (52.1%) with a sensitivity of 97.7% (95% CI, 91.8%-99.7%) and a NPV of 99.4% (95% CI, 97.7%-99.9%), and the 0/1-hour algorithm ruled out 309 of 593 patients (52.1%) with a sensitivity of 97.7% (95% CI, 91.8%-99.7%) and a NPV of 99.4% (95% CI, 97.7%-99.9%).
The performance of all 4 strategies among patients presenting within the first 4 hours from chest pain onset is shown in online-only Data Supplement Table II (onlineonly Data Supplement Appendix).
The 4 strategies showed consistent and overall favorable performance characteristics in the additional subgroup analyses according to sex, age, known coronary artery disease, and estimated glomerular filtration rate. AMI indicates acute myocardial infarction; CABG, coronary artery bypass grafting; CAD, coronary artery disease; CPO, chest pain onset; hs-cTnI, highsensitivity cardiac troponin I; hs-cTnT, high-sensitivity cardiac troponin T; NA, not available; NSTEMI, non-ST-segment-elevation myocardial infarction; PCI, percutaneous coronary intervention; and UA, unstable angina. *Highest serial measured troponin concentration.
Incorporation of ECG Findings
ECG findings indicative of possible AMI were very infrequent among patients triaged toward rule-out by the 4 hs-cTnI-based strategies. They were noted in 2% (STsegment depression) and 4% to 6% (ST-segment depression or T-wave inversion) of patients, respectively. Incorporating ECG findings indicative of possible AMI did result in only a marginal reduction in the percentage of patients eligible for rule-out, and only a marginal increase in sensitivities and NPVs, as well, in comparison with the use of the hs-cTnI-based strategies alone (Table 3) .
Comparison With the 0/3-Hour Algorithm
A total of 1044 of 2828 patients (36.9%) also had hs-cTnI measurements at 3 hours and therefore qualified for this Figure 2 . Various low concentrations of hs-cTnI.
Comparison of various low concentrations of hs-cTnI used as single cutoffs for rule-out of AMI with resulting sensitivity, negative predictive value, and effectiveness. AMI indicates acute myocardial infarction; CI, confidence interval; and hs-cTnI, high-sensitivity cardiac troponin I. subgroup analysis. Among these patients, 405 of 1044 patients (38.8%) presented >6 hours after chest pain onset and therefore qualified for rule-out with the hs-cTnI measurement (criteria: below the 99th percentile) at presentation only. This allowed triage toward rule-out in 182 of 405 patients (44.9%) with a sensitivity of 93.1% (95% CI, 83.3%-98.1%) and NPV of 97.8% (95% CI, 94.5%-99.4%). The other 639 of 1044 patients (61.2%), presented within 6 hours from chest pain onset and therefore required measurement of hs-cTnI at presentation and after 3 hours for rule-out (criteria: both below the 99th percentile). This allowed triage toward rule-out in 483 of 639 patients (75.6%) with a sensitivity of 91.9% (95% CI, 84.0%-96.7%) and NPV of 98.6% (95% CI, 97.0%-99.4%).
In total, the 0/3-hour algorithm ruled out 665 of 1044 patients (63.7%) with a sensitivity of 92.4% (95% CI, 86.7%-96.1%) and NPV of 98.4% (95% CI, 97.1%-99.2%).
The performance of the 4 very early hs-cTnI strategies in this subgroup was comparable to that in the overall cohort (online-only Data Supplement Table III) .
Prognostic Performance of Rule-Out Strategies to Predict Death During Follow-Up
The prognostic performance of each strategy is shown in Figure 4 . Of all patients classified as rule-out by the hs-cTnI 0/1-hour algorithm, the hs-cTnI 1-hour algorithm and the single cutoff approach, there was 1 death (noncardiac) within 30 days (survival rate, 99.9%), 15 deaths (2 cardiac) within 1 year (98.9%), and 23 deaths (5 cardiac) within 2 years of follow-up (98.1%, Figure 4 ). Patients ruled out by the LOD approach had 2-year survival rates of 100% (P<0.01 for LOD versus each of the other 3 strategies).
MACE Within 30 Days
There were 0 of 453 (0%) MACE in patients ruled out by the LOD strategy, 1 of 1516 (0.1%) MACE in patients ruled out by the single cutoff strategy, 1 of 1459 (0.1%) MACE in patients ruled out by the 1-hour algorithm, and 1 of 1463 (0.1%) MACE in patients ruled out by the 0/1-hour algorithm. 
DISCUSSION
This large multicenter study was performed to directly compare 4 recently developed promising early rule-out strategies for AMI to help clinicians in the selection of the most attractive strategy for routine clinical care.
Sensitivity and NPV were very high for all 4 strategies, further supporting their safety and suitability for routine clinical application. Safety, as quantified by the sensitivity and NPV, was highest for LOD (<2 ng/L, 100%), intermediate for the 1-hour algorithm and the 0/1-hour algorithm, and lowest for the single cutoff strategy (<5 ng/L). Predefined subgroup analyses in early presenters revealed significantly lower sensitivity (94.2%, interaction P=0.03) of the single cutoff, but not of the other strategies. Differences in effectiveness between the 4 strategies were substantial. The LOD strategy triaged 16% of patients toward rule-out of AMI, whereas the single cutoff strategy, the 1-hour algorithm, and the 0/1hour algorithm triaged more than half of all patients toward rule-out. Two-year survival was very high in patients triaged toward rule-out of AMI by all strategies. Again, survival was highest in LOD patients. ECG findings indicative of possible AMI (ST-segment depression and T-wave inversion) were noted only very infrequently among patients triaged toward rule-out by the 4 hs-cTnI strategies and provided only marginal incremental value regarding sensitivity and NPV on top of the respective hs-cTnI-based strategies. Overall, there seemed to be a reciprocal and well-balanced relationship between safety and effectiveness for all single cutoff values between 2 ng/L and 5 ng/L. Finally, the 0/3-hour algorithm triaged a high percentage of patients toward rule-out, but had lower sensitivity and NPV in comparison with the very early strategies.
Our findings corroborate and extend previous work on the development and validation of safe and effective rule-out strategies for AMI. 11, 19, 20, [26] [27] [28] The 4 very early hs-cTnI-based strategies analyzed in this study may be considered the most attractive, because they allow ruleout with a single measurement at presentation, which is available to clinicians usually at ≈1 hour after ED presentation or when using the 1-hour algorithm at ≈2 hours, then the results of the 1-hour sample will be available to clinicians in most hospitals.
The key advantage of the 1-hour algorithm and the 0/1-hour algorithm is that they also provide detailed guidance for the rule-in of AMI. On the other hand, the need for 2 measurements is a logistic disadvantage in comparison with the single-measurement strategies. Because of its stringent and robust methodology, this study also provided accurate estimates for the real sensitivity and NPV of the respective strategies. 29 Subgroup analyses provided important additional insights for clinical practice. The release of cTn into the circulation following cardiomyocyte damage is a time-dependent phenomenon. Accordingly, single-measurement approaches may miss AMI in previous healthy individuals with very low cTn blood concentrations below the chosen cutoff level (5 ng/L), who present very early after chest pain onset. This finding had emerged already from previous diagnostic studies 13, 14 and was confirmed in this analysis, further supporting current European Society of Cardiology guideline recommendation to only apply them in patients with chest pain onset at least 3 hours before presentation. 2 In contrast, the 1-hour algorithm, which includes early changes in hs-cTn irrespective of the absolute blood concentration achieved, seems to perform equally well irrespective of chest pain onset. All 4 strategies showed consistent and overall favorable performance characteristics in the additional subgroup analyses according to sex, age, known coronary artery disease, and estimated glomerular filtration rate. This is very reassuring and further supports the utility of these rule-out strategies for routine clinical practice.
To the best of our knowledge, no general consensus has been reached as to what sensitivity should be considered safe and acceptable for an AMI rule-out strategy. Recent studies investigating hs-cTn-based early rule-out strategies for AMI reported sensitivities ranging from 98% to 100%. 11, 19, 28, 30 In an international survey, ED physicians were asked for their opinions on an acceptable risk of missed AMI, and subsequent MACE, in patients with chest pain released from the ED. Most physicians believed a sensitivity of at least 99% is required. 31 In contrast, emerging data suggested that the sensitivity achieved in real-life clinical care (without rapid hs-cTnIbased protocols) is substantially lower. 32 When putting the findings of our study into perspective with the desired overall sensitivities, it is important to highlight that all rapid hs-cTn-based rule-out strategies should be used in conjunction with full clinical assessment and the ECG. Accordingly, the final sensitivity achieved by the combination of the individual rapid hs-cTnI rule-out strategies with clinical assessment and the ECG will be even slightly higher than that reported for the hs-cTnI-strategies only. Carlton et al investigated the performances of hs-cTnT and hs-cTnI in combination with well-established risk scores (m-Goldman, TIMI, GRACE [Global Registry of Acute Coronary Events], HEART [history, ECG, age, risk factors, troponin], and Vancouver Chest Pain Rule) and ECG data. They reached the highest possible sensitivity for rule-out of AMI using the Vancouver Chest Pain Rule (incorporates hs-cTnT or hs-cTnI) of 100% (95% CI, 94.4%-100%) and 100% (95% CI, 93.3%-100%), respectively. 33 These data suggest that the addition of scores to baseline troponin concentrations and low-risk ECG data may be helpful to further improve the early and safe rule-out of AMI with sensitivities >99%. Accordingly, a sensitivity of at least 98% for the troponin rule only could be considered a reasonable threshold for acceptance.
All 4 very early hs-cTnI-based rule-out strategies were derived using a uniform, and not sex-specific cutoffs, and were accordingly analyzed in the same way in this report. Subgroup analyses indicated equally favorable performance characteristics in women and men using Figure 4 . Two-year survival of patients ruled out for acute myocardial infarction. Two-year survival of patients ruled out for acute myocardial infarction according to the 4 very early rule-out strategies. hs-cTnI indicates high-sensitivity cardiac troponin I; and LOD, limit of detection.
these strategies, suggesting that sex-specific cutoff levels may not provide any benefit once using one of these very early strategies. Further research is necessary to explore this important question in more detail. [34] [35] [36] [37] It is important to highlight that all hs-cTnI-based ruleout strategies should always be used in conjunction with all other information available to the clinicians including vital signs, the 12-lead ECG, and chest pain characteristics. 2 The combination with quantified clinical judgment seems particularly valuable, because it has been shown to help identify patients with unstable angina, the more benign acute coronary syndrome phenotype. 2, 38 Moreover, beyond the very early strategies examined in these analyses, several additional rule-out strategies including the 2-hour algorithm, the 2-hour accelerated diagnostic protocol, the 0/3-hour algorithm, and the combination of hs-cTn with copeptin merit consideration for clinical use. 2, 14, 16, 20, 26, 27, 39, 40 Some limitations merit consideration when interpreting these findings. Our study was conducted in ED patients with symptoms suggestive of AMI. Further studies are required to quantify the utility of rule-out strategies in patients with either a higher pretest probability (eg, in a coronary care unit setting) or in patients with a lower pretest probability (eg, in a general practitioner setting) for AMI. No specific sample size calculation was performed. Although this secondary analysis from an ongoing multicenter study is one of the largest ever performed, it still may have been underpowered for some comparisons among 4 strategies. Not all patients with acute chest pain had a second set of laboratory measurements at 1 hour. The most common reasons for missing blood samples were logistic issues in the ED that precluded blood draw around the 1-hour window. However, it is unlikely that the absence of these patients significantly influenced our results. Although we used the most stringent methodology to adjudicate the presence or absence of AMI, including central adjudication by experienced cardiologists and serial measurements of hs-cTn, we still may have misclassified a small number of patients. 3, 21 Our findings are specific to the only hs-cTnI assay currently available for routine clinical care. Once other hscTnI assays become available for clinical care, additional studies will need to examine whether our findings can be generalized to them. Finally, we cannot generalize our findings to patients with terminal kidney failure requiring dialysis, because they were excluded from this study.
In conclusion, all 4 hs-cTnI-based rule-out strategies seem to balance effectiveness and safety equally well. Other differences including, eg, the additional guidance for rule-in of the 1-hour algorithm and the 0/1hour algorithm or the ease of the single-measurement strategies will help in the selection for routine clinical care. The single cutoff should not be applied in early presenters, whereas the 3 other strategies seem to perform well in this challenging subgroup.
